Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Clonal human neurons re-establish connection in rats with severe spinal cord injury, USF study finds

01.07.2002


Human neurons grown as cells cloned from a tumor helped restore the function of severely injured spinal cords in rats, University of South Florida researchers say in a study released this week in the Journal of Neurosurgery: Spine.



"Transplants of these specially treated cells were used to patch a short circuit in the spinal cord of rats," said Samuel Saporta, PhD, associate director of the USF Center for Aging and Brain Repair, professor of anatomy and lead author of the study. "We demonstrated the cells are safe, survive and can electrically reconnect the undamaged parts of the spinal cord."

A couple of the spinal cord-injured (SCI) rats could bear weight on their hind legs following transplantation with the experimental cells, known commercially as hNT, or LBS, neurons. However, the researchers emphasize, more studies are needed to determine if rats with reconnected spinal cords can walk again.


"We are hopeful that our work with hNT neurons in an animal model for spinal cord injury will ultimately lead to the first transplant of human neural progenitor cells to treat spinal cord injury in humans," said neuroscientist Paul R. Sanberg, PhD, DSc, director of the USF Center for Aging and Brain Repair and a study co-author.

Dr. Saporta, Dr. Sanberg and colleagues at USF conducted preclinical research with hNT neurons that led to the first transplant to repair brain damage from stroke in 1998. That clinical trial, ongoing at the University of Pittsburgh Medical Center, has shown initial promise in improving the function of a small group of stroke patients.

HNT neurons originate from a rare human cancer characterized by the presence of immature or "progenitor" cells. These rapidly dividing tumor cells have the capacity to differentiate into neurons, each a clone of the original cells.

The cells can be treated with retinoic acid in the laboratory to prompt them into becoming fully committd, non-dividing neurons. Research in both animals and humans has shown that these hNT neurons do not revert to cancer cells.

The USF team studied three groups of rats with severe SCI. One group was administered hNT neurons immediately following injury, another received transplants two weeks after SCI injury, and the third, a control group, received no transplant.

The spinal cord, which runs from the brain to the end of the spine, is like an electrical circuit that sends messages to and from the brain to the rest of the body. If the spinal cord is damaged or severed, however, the electrical activity either stops from the point of injury downward or provides faulty messages.

All seven animals in the delayed transplant group recovered electrical activity in the spinal cord neurons that control muscle movement. Only two of nine animals in the immediate transplant group did. In addition this electrical activity — known as motor evoked potentials or MEPs — measured much stronger in the delayed transplant group than in rats receiving hNT neurons immediately after injury. The untreated SCI rats had no improvement in motor neuron transmission.

The researchers suspect that the better recovery results in the animals with delayed transplants, compared to those transplanted right after injury, may be due to a less hostile immune environment as time passes. Immediately following injury, Dr. Saporta said, inflammatory substances called cytokines recruit immune cells to clear all foreign material away from the area of injury — including, perhaps some of the transplanted hNT neurons.

Pathological examination showed that the transplanted hNT neurons, injected into the spinal cord at the site of injury, maintained the characteristics of neurons. The cells sprouted fibers, or axons, that grew into the undamaged, intact portions of the spinal cord above and below the injured area.

Although two transplanted animals were able to bear weight, none of the rats walked following treatment with the dose of hNT neurons administered in this study.

The transplanted cells appear to fill in the area of damage and re-establish a neural connection, Dr. Saporta said. "This suggests it may be possible to teach the spinal cord, through rehabilitation, how to send out appropriate signals to the muscles so the animal can walk again … That’s the next step."

Layton BioScience Inc. of Atherton, CA, holds the license for hNT neuron transplantation technology and is developing the cells for the treatment of several neurological disorders.

In addition to Dr. Saporta and Dr. Sanberg, other authors of the study were Shahram Makoui, MD; Alison Willing, PhD, and David Cahill, MD, all of the USF Center for Aging and Brain Repair; and Marcel Daadi, PhD; of Layton Bioscience, Inc.

Anne DeLotto Baier | EurekAlert!

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Water - as the underlying driver of the Earth’s carbon cycle

17.01.2017 | Earth Sciences

Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

17.01.2017 | Materials Sciences

Smart homes will “LISTEN” to your voice

17.01.2017 | Architecture and Construction

VideoLinks
B2B-VideoLinks
More VideoLinks >>>